Home > ABOUT > Overview



October, 2013 UPDATE:

Screening Compounds

Fragment library


Overview
OTAVA Ltd. (est. 1997) is an international science-based chemical company that specializes in development and production of featured chemicals, bio-chemicals and bioanalytical reagents. For almost 20 years we have been providing quality products and services for pharma, biotech and R&D companies, academic institutions and government agencies.
 
We offer more than 250,000 compounds for high-throughput screening (HTS) including >300 target-focused libraries (Kinase, Protease, GPCR, Ion Channel, Epigenetic Targets and others) as well as libraries of Fragments, Lead-like, Drug-like and CNS compounds. Custom library design is available on your request.
 
Our special focus is protein kinase R&D and drug discovery including hit identification & optimization, in silico & in vitro screenings, structure- and ligand-based drug design.
 
OTAVA’s facilities and long-standing experience make possible a variety of contract research and collaborative research projects. We already collaborate with many companies and academic institutions in Europe, US and Canada, and we hope you will consider working with us. Our team of highly skilled and talented medicinal chemists, biologists and computational chemists is ready to facilitate hit identification, hit-to-lead optimization  or custom synthesis project of any level. The synthetic work could involve extensive application of cheminformatics, molecular modeling and computational chemistry techniques. Send us your compound structure now and evaluate our competitive prices and fast turn-around time.
 
 

OTAVA is an acknowledged leader in providing:

  • Synthesis of high-quality small organic compounds for HTS, chemical building blocks and intermedieates
  • Full range of custom synthesis and hit-to-lead optimization services
  • Rational design of inhibitors of protein kinases and other drug targets
  • Wide selection of target-focused libraries, design on request option
  • Molecular modeling/computational chemistry services
  • Development of novel fluorescent probes